nach oben

The Patient - Patient-Centered Outcomes Research

Erschienen in:

01.01.2011 | Review Article

Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life

A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess Health-Related Quality of Life in End-Stage Renal Disease

verfasst von: Cheryl Glover, Pauline Banks, Amanda Carson, Professor Colin R. Martin, Tim Duffy

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Advances in healthcare, combined with an increasing number of adults with end-stage renal disease (ESRD), mean that there is a growing number of people now surviving on renal replacement therapy. The issue of health-related quality of life (HR-QOL) is becoming increasingly important in this area. For this reason, the content validity of various instruments used to measure HR-QOL in an ESRD population were explored.

Systematic searches of MEDLINE (1950–2009) were conducted using terms related to ESRD combined with terms associated with measuring HR-QOL. A total of 378 abstracts were identified, detailing the repeated use of six generic measures and four disease-specific measures. The generic HR-QOL measures discussed include the Medical Outcomes 36-Item Short Form Survey (SF-36), the EuroQOL 5 Dimension (EQ-5D), and the WHO QOL assessment (WHOQOL-BREF). The most frequently used disease-specific measure discussed is the Kidney Disease QOL instrument (KDQOL) and its derivative versions (KDQOL-SF, KDQOL-36).

The appropriateness of using the SF-36 in this population is challenged and recommendations include using the WHOQOL-BREF in cases when a generic instrument is required and the KDQOL-SF when a more disease-specific measurement is called for.

In this context, content validity is defined as “the degree to which elements of an assessment instrument are relevant to and representative of the targeted construct for a particular assessment purpose.”[4] (p. 238)

Ken Farrington AH, Casula A, Ansell D, et al. UK Renal Registry 11th Annual Report. Bristol: UK Renal Registry, 2008 [online]. Available from URL: http://www.renalreg.com/Reports/2008.html [Accessed 2011 Jan 6]

Cross Party Group on Kidney Disease. Renal disease in Scotland: a strategy for future management. Edinburgh: The Scottish Parliament, 2004 [online]. Available from URL: http://www.renal.org/Libraries/UK_Nephrology/Renal_Disease_in_Scotland_A_Strategy_For_Future_Management_April_2004.sflb.ashx [Accessed 2010 Dec 20]

Levy J, Pusey C, Singh A. Fast facts: renal disorders. Oxford: Health Press, 2006

Haynes SN, Richard DCS, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 1995; 7(3): 238–47CrossRef

Bowling A. Measuring health: a review of quality of life measurement scales. 3rd ed. Maidenhead: Open University Press, 2005

Phillips D. Quality of life: concept, policy and practice. London: Routledge, 2006

WHOQOL. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41(10): 1403–9CrossRef

Molzahn AE, Northcott HC, Dossetor JB. Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians. ANNA J 1997; 24(3): 325–33; discussion 34-5PubMed

Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient. Br J Cancer 1988; 57(1): 109–12PubMedCrossRef

10.

Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948

11.

Mapes DL, Lopes AA, Satayathum S, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003 Jul; 64(1): 339–49PubMedCrossRef

12.

O’Shaughnessy DV, Elder GJ. Review article: patient-level outcomes. The missing link. Nephrology (Carlton) 2009 Jun; 14(4): 443–51CrossRef

13.

Unruh ML, Weisbord SD, Kimmel PL. Health-related quality of life in nephrology research and clinical practice. Semin Dial 2005 Mar–Apr; 18(2): 82–90PubMedCrossRef

14.

Moinpour CM, Lyons B, Schmidt SP, et al. Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases. Quality Life Res 2000; 9(2): 219–31CrossRef

15.

Bass EB, Jenckes MW, Fink NE, et al. Use of focus groups to identify concerns about dialysis. Med Decis Making 1999; 19(3): 287–95PubMedCrossRef

16.

Juergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 2006 Aug; 1(6): 1191–6PubMedCrossRef

17.

Cukor D, Cohen SD, Peterson RA, et al. Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. J Am Soc Nephrol 2007 Dec; 18(12): 3042–55PubMedCrossRef

18.

Wuerth D, Finkelstein SH, Finkelstein FO. Psychosocial assessment of the patient on chronic peritoneal dialysis: an overview. Adv Chronic Kidney Dis 2007; 14(4): 353–7PubMedCrossRef

19.

Wu AW, Fink NE, Cagney KA, et al. Developing a health-related quality-of-life measure for end-stage renal disease: the CHOICE Health Experience Questionnaire. Am J Kidney Dis 2001 Jan; 37(1): 11–21PubMed

20.

Weisbord SD. Symptoms and their correlates in chronic kidney disease. Adv Chronic Kidney Dis 2007; 14(4): 319–27PubMedCrossRef

21.

Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30(6): 473–83PubMedCrossRef

22.

EuroQol: a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16(3): 199–208CrossRef

23.

Development of the World Health Organization WHO-QOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28(3): 551–8CrossRef

24.

Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19(8): 787–805PubMedCrossRef

25.

Liem YS, Bosch JL, Arends LR, et al. Quality of life assessed with the medical outcomes study short form 36-item health survey of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2007; 10: 390–7PubMedCrossRef

26.

Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35(4): 629–37PubMedCrossRef

27.

Haycox A, Jones D. The cost effectiveness of renal provision in the UK. J Manag Med 1996; 10(1): 6–15PubMedCrossRef

28.

Fan SL, Sathick I, McKitty K, et al. Quality of life of care-givers and patients on peritoneal dialysis. Nephrol Dial Transplant 2008 May; 23(5): 1713–9PubMedCrossRef

29.

Smith GC, Trauer T, Kerr PG, et al. Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation 2003 Sep; 76(5): 807–9PubMedCrossRef

30.

Shrestha A, Vallance C, McKane WS, et al. Quality of life of living kidney donors: a single-center experience. Transplant Proc 2008 Jun; 40(5): 1375–7PubMedCrossRef

31.

Bilgic A, Akman B, Sezer S, et al. Predictors for quality of life in continuous ambulatory peritoneal dialysis patients. Nephrology 2008; 13(7): 587–92PubMedCrossRef

32.

Franke GH, Trampenau C, Reimer J, et al. Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. Transplant Proc 2006 Jun; 38(5): 1293–4PubMedCrossRef

33.

Lee AJ, Morgan CL, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin 2005; 21(11): 1777–83PubMedCrossRef

34.

Manns B, Johnson JA, Taub K, et al. Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol 2003; 60(5): 341–51PubMed

35.

Manns BJ, Johnson JA, Taub K, et al. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J 2002; 48(5): 565–9PubMedCrossRef

36.

Theodora K, Christina D, Tania F, et al. Looking in to the factors affecting renal patients’ quality of life. EDTNA J 1996; 23(3): 19–21

37.

Padrao MB, Sens YAS. Quality of life of living kidney donors in Brazil: an evaluation by the short form-36 and the WHOQOL-bref questionnaires. Clin Transplant 2009 Aug; 23(5): 621–7PubMedCrossRef

38.

Ginieri-Coccossis M, Theofilou P, Synodinou C, et al. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol 2008; 9: 14PubMedCrossRef

39.

Niu S-F, Li IC. Quality of life of patients having renal replacement therapy. J Adv Nurs 2005; 51(1): 15–21PubMedCrossRef

40.

McMahon LP, Mason K, Skinner SL, et al. Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure. Nephrol Dial Transplant 2000; 15(9): 1425–30PubMedCrossRef

41.

Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, et al. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2000; 11(2): 335–42PubMed

42.

Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000; 14(3): 199–207PubMedCrossRef

43.

Hays RD, Kallich JD, Mapes DL, et al. Development of the kidney-disease quality-of-life (KDQOL) Instrument. Qual Life Res 1994 Oct; 3(5): 329–38PubMedCrossRef

44.

Laupacis A, Muirhead N, Keown P, et al. A disease-specific questionnaire for assessing quality-of-life in patients on hemodialysis. Nephron 1992; 60(3): 302–6PubMedCrossRef

45.

Franke GH, Reimer J, Kohnle M, et al. Quality of life in end-stage renal disease patients after successful kidney transplantation: development of the ESRD symptom checklist-transplantation module. Nephron 1999 Sep; 83(1): 31–9PubMedCrossRef

46.

Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 1985; 8(1): 15–24PubMed

47.

Barotfi S, Molnar MZ, Almasi C, et al. Validation of the Kidney Disease Quality of Life-Short Form questionnaire in kidney transplant patients. J Psychosomat Res 2006 May; 60(5): 495–504CrossRef

48.

Martin CR, Thompson DR. Prediction of quality of life in patients with end-stage renal disease. Br J Health Psychol 2000; 5: 41–55CrossRef

49.

Lefebvre P, Vekeman F, Sarokhan B, et al. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa. Curr Med Res Opin 2006 Oct; 22(10): 1929–37PubMedCrossRef

50.

Provenzano R, Garcia-Mayol L, Suchinda P, et al. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clinical Nephrol 2004 Jun; 61(6): 392–405

51.

Neto JFR, Ferraz MB, Cendoroglo M, et al. Quality of life at the initiation of maintenance dialysis treatment: a comparison between the SF-36 and the KDQ questionnaires. Qual Life Res 2000 Feb; 9(1): 101–7PubMedCrossRef

52.

Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in haemo-dialysis patients. Nephrol Dial Transplant 1997 Oct; 12(10): 2111–6PubMedCrossRef

53.

Franke GH, Yucetin L, Yaman H, et al., editors. Disease-specific quality of life in Turkish patients after successful kidney transplantation. 8th Meeting of the Turkish-Transplantation-Society; 2005 Jun 22–24; Ankara. New York: Elsevier Science Inc., 2006

54.

Franke GH, Reimer J, Philipp T, et al. Aspects of quality of life through end-stage renal disease. Qual Life Res 2003 Mar; 12(2): 103–15PubMedCrossRef

55.

Cetingok M, Winsett RP, Hathaway DK. A comparative study of quality of life among the age groups of kidney transplant recipients. Prog Transplant 2004; 14(1): 33–8

56.

Johnson CD, Wicks MN, Milstead J, et al. Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Sch 1998; 30(2): 125–30PubMedCrossRef

57.

Kouidi E, Iacovides A, Iordanidis P, et al. Exercise renal rehabilitation program: psychosocial effects. Nephron 1997; 77(2): 152–8PubMedCrossRef

58.

Dunn SA, Lewis SL, Bonner N, et al. Quality of life for spouses of CAPD patients. ANNA J 1994; 21(5): 237–46PubMed

Titel: Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life
A Systematic Review of the Content Validity of Self-Administered Instruments Used to Assess Health-Related Quality of Life in End-Stage Renal Disease
verfasst von: Cheryl Glover
Pauline Banks
Amanda Carson
Professor Colin R. Martin
Tim Duffy
Publikationsdatum: 01.01.2011
Verlag: Springer International Publishing
Erschienen in: The Patient - Patient-Centered Outcomes Research / Ausgabe 1/2011
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI: https://doi.org/10.2165/11584650-000000000-00000

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

A Qualitative Study on Feasibility of a Web-Based Women’s Health Portal and Information System

Patient Preferences for Treatment of Achilles Tendon Pain

Patient-Reported Outcomes, Patient-Reported Information

Development of an Electronic Daily Uterine Fibroid Symptom Diary

Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence

Family Burden after Severe Brain Injury